Agilent Technologies Introduces Advanced Zebrafish, Mouse Microarrays For Stem Cell And Developmental Biology Research

Agilent Technologies Inc. recently introduced the industry's most up-to-date microarray to provide genome-wide coverage of the zebrafish (Danio rerio), and the first commercial whole mouse genome microarray based on the National Institute on Aging (NIA) Mouse Gene Index. The zebrafish and mouse microarrays were developed in collaboration with Icoria (a member of the Toxicogenomics Consortium) and the NIA, respectively.

"This is part of our concerted effort to provide a substantial portfolio of microarray-based genomic tools and solutions for key areas of research, such as stem cells and developmental biology," said Fran DiNuzzo, Agilent vice president and general manager, Integrated Biology Solutions, Life Sciences and Chemical Analysis. "We believe researchers should enjoy easy access to high-quality microarrays featuring current content for their model organism of choice."

Combined with Agilent's integrated portfolio of reagents, hardware, informatics and catalog microarrays, these new designs expand researchers' ability to perform highly detailed genetic research, functional genomics, gene discovery and identification, pathway analysis and drug discovery and development. Model organisms allow cross-species research that can be applied to humans. Researchers can access the content of these microarrays using Agilent's eArray (earray.chem.agilent.com), a Web-based microarray design tool that allows scientists to mine the most up-to-date content of Agilent's catalog arrays and design custom arrays for their own experiments.

SOURCE: Agilent Technologies Inc.